Join
Live feed
·
PRReleasevia Quantisnow
Turnstone Biologics Corp. logo
XOMA Royalty Corporation logo

Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TSBX (Turnstone Biologics Corp.), XOMA (XOMA Royalty Corporation) and more on Quantisnow.